Sign in

Private company

Reunion Neuroscience

Logo: reunionneuro.com3

Reunion Neuroscience is an American biotechnology company based in Morristown, founded in 2022.1 Its website says: “Reunion Neuroscience is a clinical stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.”3

Last updated Oct 21, 2026.

Overview

-48.5MNet income, fiscal 20234
2022Founded1
  • Industrybiotechnology, pharmaceutical industry1
  • HeadquartersMorristown1
  • Websitereunionneuro.com
  • Incorporated inDE5
  • Business address1 High Street Court, Morristown, Nj 079605
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.

Key numbers, fiscal 2022

-1125.3%Net margin4
405.8%Revenue growth, 20226
-81.7%Return on equity4
0.00×Debt to equity4
-47.2M CADFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development86¢7.0M CAD
  • Interest14¢1.1M CAD

Out of 4.9M CAD in revenue.64 The company lost money this year.

Financial statements

Revenue64.9M CAD in 2022+406% since 2021
02.0M CAD4.0M CAD6.0M CAD2021: 960.9K CAD960.9K CAD20212022: 4.9M CAD4.9M CAD2022+406%
Net income64-54.7M CAD in 2022+137% since 2021
-60.0M CAD-40.0M CAD-20.0M CAD02021: -23.1M CAD-23.1M CAD20212022: -54.7M CAD-54.7M CAD2022+137%
Fiscal year202020212022
Revenue960.9K CAD64.9M CAD6
Research and development7.0M CAD4
Interest1.1M CAD6
Income before tax-54.7M CAD6
Net income-23.1M CAD6-54.7M CAD4
Earnings per share-1 CAD/shares6-1 CAD/shares4
Earnings per share (diluted)-1 CAD/shares6-1 CAD/shares4
Shares (weighted, basic)57.8M shares4
Shares (weighted, diluted)57.8M shares4

Compare Reunion Neuroscience with another company

Corporate structure

Reunion Neuroscience sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Reunion Neuroscience

  • Reunion Neuroscience Morristown

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerEdward Smith named Sep 9, 20257
  • Executive Officer, DirectorGregory Mayes named Sep 9, 20257
  • Executive OfficerMark Pollack named Sep 9, 20257
  • Executive OfficerMark Theeuwes named Sep 9, 20257
  • Executive OfficerNathan Bryson named Sep 9, 20257
  • DirectorAlon Lazarus named Sep 9, 20257
  • DirectorAnsbert Gadicke named Sep 9, 20257
  • DirectorEllen Lubman named Sep 9, 20257
  • DirectorMichael Ehlers named Sep 9, 20257
  • DirectorNatalie Sacks named Sep 9, 20257

Former names

  • Reunion Neuroscience Management, Inc.Jan 25, 2024 to May 6, 20245

Timeline

  1. 2022Founded Founded1

Calendar

Drug trials and FDA: coming up

  1. Nov 2026Phase 2 trial readout expected Phase 2 trial of RE104 for Injection in Adjustment Disorder: primary completion expected Nov 2026 (ClinicalTrials.gov NCT07002034).8
  2. Jul 2027Phase 2 trial readout expected Phase 2 trial of RE104 for Injection in Generalized Anxiety Disorder: primary completion expected Jul 2027 (ClinicalTrials.gov NCT07489651).9

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Filings

45 filings to the SEC since October 2021: 2 annual reports, 3 large holders, 4 private raises, 36 other. The latest 20:

  1. Sep 9, 2025D/A EDGAR
  2. May 5, 2025D/A EDGAR
  3. May 6, 2024D/A EDGAR
  4. Jan 25, 2024D EDGAR
  5. Aug 18, 202315-12G EDGAR
  6. Aug 1, 2023SC 13D/A EDGAR
  7. Aug 1, 20236-K EDGAR
  8. Aug 1, 2023F-10POS EDGAR
  9. Aug 1, 2023S-8 POS EDGAR
  10. Aug 1, 2023S-8 POS EDGAR
  11. Jul 19, 20236-K EDGAR
  12. Jul 13, 20236-K EDGAR
  13. Jul 7, 20236-K EDGAR
  14. Jun 29, 202340-F EDGAR
  15. Jun 20, 20236-K EDGAR
  16. Jun 20, 2023SC 13G EDGAR
  17. Jun 12, 2023SC 13D EDGAR
  18. Jun 12, 20236-K EDGAR
  19. Jun 1, 20236-K EDGAR
  20. Apr 25, 20236-K EDGAR

The 45 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$119.8M 2024–2024
Money received by yearMoney received by year, 2024–2024: $119.8M in all. Private raises (Form D) $119.8M.$0$50M$100M$150M2024 · Private raises (Form D): $119.8M2024
Figures by year
YearPrivate raises (Form D)Total
2024$119.8M$119.8M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Jan 12, 2024Raised $119.8 million in a private offering of equity7 Form D: 9 investors so far Form D

SEC filer profile

How Reunion Neuroscience is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARReunion Neuroscience, Inc.2
  • CIK0002007993
  • Employer ID (EIN)93-23212252
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Business address1 High Street Court, Morristown, NJ 079602
  • Phone888-880-73862
  • On EDGAR sinceJan 25, 20242
  • Filings4 in all: D/A (3), D (1)2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11